Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02252's PB Ratio is ranked worse than 99.11% of 783
companies
in the Medical Devices & Instruments industry
Industry Median: 2.13
vs HKSE:02252: 57.91
During the past 12 months, Shanghai MicroPort MedBot (Group) Co's average Book Value Per Share Growth Rate was 49.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -35.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -35.00% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai MicroPort MedBot (Group) Co was 276.30% per year. The lowest was -54.10% per year. And the median was -33.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Shanghai MicroPort MedBot (Group) Co PB Ratio Related Terms
Shanghai MicroPort MedBot (Group) Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai MicroPort MedBot (Group) Co PB Ratio Chart
For the Medical Devices subindustry, Shanghai MicroPort MedBot (Group) Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai MicroPort MedBot (Group) Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai MicroPort MedBot (Group) Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Shanghai MicroPort MedBot (Group) Co's PB Ratio falls into.
Shanghai MicroPort MedBot (Group) Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Shanghai MicroPort MedBot (Group) Co (HKSE:02252) has a PB Ratio of 57.91 as of Aug. 14, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai MicroPort MedBot (Group) Co and its competitors. This is 225% above median its historical median of 17.84. Over the past decade, Shanghai MicroPort MedBot (Group) Co's PB Ratio has ranged from 6.44 to 104.27. According to the industry distribution chart, Shanghai MicroPort MedBot (Group) Co ranks #776 out of 783 companies in the Medical Devices & Instruments industry, placing it in the top 99.1%.
Is Shanghai MicroPort MedBot (Group) Co's PB Ratio too high?
Shanghai MicroPort MedBot (Group) Co's current PB Ratio of 57.91 is 225% above median its 10-year median of 17.84. Over the past 10 years, this metric has ranged from a low of 6.44 to a high of 104.27. The Medical Devices & Instruments industry median PB Ratio is 2.13. Shanghai MicroPort MedBot (Group) Co's value of 57.91 is 2618.8% above this industry median. Based on the distribution chart, Shanghai MicroPort MedBot (Group) Co ranks #776 out of 783 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shanghai MicroPort MedBot (Group) Co has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai MicroPort MedBot (Group) Co's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai MicroPort MedBot (Group) Co ranks #776 out of 783 companies for PB Ratio. This places Shanghai MicroPort MedBot (Group) Co in the lower half of its industry. The industry median PB Ratio is 2.13. Shanghai MicroPort MedBot (Group) Co's value of 57.91 is 2618.8% above this benchmark. Historically, Shanghai MicroPort MedBot (Group) Co's own PB Ratio has ranged from 6.44 to 104.27 over the past decade. While the company's 10-year median is 17.84 vs. the industry median of 2.13, Shanghai MicroPort MedBot (Group) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.13, based on 783 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai MicroPort MedBot (Group) Co's current PB Ratio of 57.91 is 2618.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai MicroPort MedBot (Group) Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai MicroPort MedBot (Group) Co's current PB Ratio is 57.91, which is 225% above median its own 10-year median of 17.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai MicroPort MedBot (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai MicroPort MedBot (Group) Co (HKSE:02252) is currently considered Possible Value Trap. The stock's GF Value™ is HK$81.81, compared to a current price of HK$25.48 — trading 68.9% below its estimated fair value. The current PB Ratio is 57.91, which is 225% above median its 10-year median of 17.84 and 2618.8% above the Medical Devices & Instruments industry median of 2.13. Shanghai MicroPort MedBot (Group) Co's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Shanghai MicroPort MedBot (Group) Co (HKSE:02252), the current PB Ratio is 57.91 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai MicroPort MedBot (Group) Co stock appears to be undervalued.
The current stock price of HK$25.48 is trading 68.9% below its estimated GF Value™ of HK$81.81.
GuruFocus considers Shanghai MicroPort MedBot (Group) Co to be Possible Value Trap.
Key valuation signals for HKSE:02252:
PB Ratio: 57.91 (225% above median its 10-year median of 17.84)
GF Value™: HK$81.81 vs. price of HK$25.48 (68.9% below fair value)
Industry Position: 2618.8% above the Medical Devices & Instruments median (#776 of 783)
No single metric tells the full story. See the HKSE:02252 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai MicroPort MedBot (Group) Co Ltd is a surgical robot company dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures. The business of the company covers various surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures, and has accumulated several products at various stages as those in development, clinical trials, registration, and commercialisation. The company derives revenue principally from the sales of surgical robot systems, instruments, and accessories, and the provision of services through appointed distributors. Geographically, it derives maximum revenue from the People's Republic of China.
45GF Score
Get the complete analysis for HKSE:02252
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02252 has been successfully added to your 
